Literature DB >> 16309711

Up-regulation of integrin-linked kinase activity in rat mesangioproliferative glomerulonephritis.

Shoji Kagami1, Maki Shimizu, Shuji Kondo, Akiko Kitamura, Maki Urushihara, Masanori Takamatsu, Satoshi Yamaji, Yoshiaki Ishigatsubo, Hiroshi Kawachi, Fujio Shimizu.   

Abstract

This study investigated whether integrin-linked kinase (ILK) is involved in the pathogenesis of chronic glomerulonephritis (GN) by analyzing the expression and activity of glomerular ILK in a chronic rat model of mesangioproliferative GN. Double immunostaining of kidneys obtained at different time points with glomerular cell-specific markers revealed that ILK was primarily expressed by glomerular epithelial cells, and weakly by mesangial cells (MCs) and endothelial cells in control rats, but dramatically increased in a typical mesangial pattern at days 21 and 28 of GN. Semiquantitative assessment indicated that the level of glomerular ILK expression closely parallels the level of accumulation of glomerular extracellular matrix (ECM) as well as fibronectin (FN). Immunoprecipitation and kinase activity assays using isolated nephritic glomeruli indicated a striking increase of ILK activity on days 21 and 28 of GN. Further, cultured rat MCs overexpressing kinase-deficient ILK diminished FN assembly and collagen matrix remodeling as compared with control transfectants. The results showed that glomerular ILK expression and activity are markedly increased in an experimental model of chronic GN. Increased activity of ILK in MCs may contribute to the development of chronic mesangial alterations leading to glomerular scarring.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309711     DOI: 10.1016/j.lfs.2005.08.037

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Integrin-linked kinase in the vascular smooth muscle cell response to injury.

Authors:  Bernard Ho; Guangpei Hou; J Geoffrey Pickering; Gregory Hannigan; B Lowell Langille; Michelle P Bendeck
Journal:  Am J Pathol       Date:  2008-06-05       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.